Abstract
Nitric oxide (NO) produced in the heart by nitric oxide synthase (NOS) is a highly reactive signaling molecule and an important modulator of myocardial function. NOS catalyzes the conversion of l-arginine to l-citrulline and NO but under particular circumstances reactive oxygen species (ROS) can be formed instead of NO (uncoupling). In the heart, three NOS isoforms are present: neuronal NOS (nNOS, NOS1) and endothelial NOS (eNOS, NOS3) are constitutively present enzymes in distinct subcellular locations within cardiomyocytes, whereas inducible NOS (iNOS, NOS2) is absent in the healthy heart, but its expression is induced by pro-inflammatory mediators. In the tissue, NO has two main effects: (i) NO stimulates the activity of guanylate cyclase, leading to cGMP generation and activation of protein kinase G, and (ii) NO nitrosylates tyrosine and thiol-groups of cysteine in proteins. Upon nitrosylation, proteins may change their properties. Changes in (i) NOS expression and activity, (ii) subcellular compartmentation of NOS activity, and (iii) the occurrence of uncoupling may lead to multiple NO-induced effects, some of which being particularly evident during myocardial overload as occurs during aortic constriction and myocardial infarction. Many of these NO-induced effects are considered to be cardioprotective but particularly if NOS becomes uncoupled, formation of ROS in combination with a low NO bioavailability predisposes for cardiac damage.
Similar content being viewed by others
Abbreviations
- NO:
-
Nitric oxide
- nNOS:
-
Neuronal nitric oxide synthase
- eNOS:
-
Endothelial nitric oxide synthase
- iNOS:
-
Inducible nitric oxide synthase
- IFN:
-
Interferon
- LPA:
-
Lipopolysaccharide
- cGMP:
-
Cyclic guanosine monophosphate
- GTP:
-
Guanosine triphosphate
- PKG:
-
Protein kinase G
- LV:
-
Left ventricle
- RGD:
-
Arg-gly-asp motif (in peptide)
- IL6:
-
Interleukin 6
- TNFα:
-
Tumor necrosis factor alpha
- l-NAME:
-
Nω-nitro-l-arginine methyl ester
- ACE:
-
Angiotensin converting enzyme
- ROS:
-
Reactive oxygen species
- RyR:
-
Ryanodine receptor
- SR:
-
Sarcoplasmic reticulum
- MMP:
-
Matrix metalloproteinase
- IL-1β:
-
Interleukin-1 beta
- SERCA:
-
Sarcoplasmic reticulum calcium ATPase
- P O :
-
Probability of a channel to be open
- RV:
-
Right ventricle
- NADPH:
-
Nicotinamide adenine dinucleotide phosphate
- CHF:
-
Congestive heart failure
- l-NMMA:
-
N G-monomethyl-l-arginine
- XOD:
-
Xanthine oxidoreductase
- BH4 :
-
Tetrahydrobiopterin
References
Wang Y, Marsden PA (1995) Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 34:71–90
Xie Q-W, Nathan C (1994) The high-output nitric oxide pathway: role and regulation. J Leukocyte Biol 56:576–582
Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417–2423
Keira N, Tatsumi T, Matoba S et al (2002) Lethal effect of cytokine-induced nitric oxide and peroxynitrite on cultured rat cardiac myocytes. J Mol Cell Cardiol 34:583–596
Mannick JB, Schonhoff CM (2002) Nitrosylation: the next phosphorylation? Arch Biochem Biophys 408:1–6
Martinez-Ruiz A, Lamas S (2004) S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 62:43–52
Hess DT, Matsumoto A, Kim SO et al (2005) Protein S-nitrosylation: purview and parameters. Nat Mol Cell Biol 6:150–166
Campbell DL, Stamler JS, Strauss HC (1996) Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108:277–293
Hu H, Chiamvimonvat N, Yamagishi T et al (1997) Direct inhibition of expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide donors. Circ Res 81:742–752
Sun J, Picht E, Ginsburg KS et al (2006) Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel α1 subunit and reduced ischemia-reperfusion injury. Circ Res 98:403–411
Nunez L, Vaquero M, Gomez R et al (2006) Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res 72:80–89
Lokuta AJ, Maertz NA, Vadakkadath Meethal S et al (2005) Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation 111:988–995
Xu L, Eu JP, Meissner G et al (1998) Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279:234–237
Eu JP, Xu L, Stamler JS et al (1999) Regulation of ryanodine receptors by reactive nitrogen species. Biochem Pharmacol 1079–1084
Liu L, Hausladen A, Zeng M et al (2001) A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410:490–494
Liu L, Yan Y, Zeng M et al (2004) Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 116:617–628
Dimmeler S, Haendeler J, Nehls M et al (1997) Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 185:601–607
Nikitovic D, Holmgren A, Spyrou G (1998) Inhibition of AP-1 DNA binding by nitrix oxide involving conserved cysteine residues in Jun and Fos. Biochem Biophys Res Commun 242:109–112
Mannick JB, Hausladen A, Liu L et al (1999) Fas-induced caspase denitrosylation. Science 284:651–654
Park HS, Huh SH, Kim MS et al (2000) Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc Natl Acad Sci USA 97:14382–14387
Park HS, Yu JW, Cho JH et al (2004) Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism. J Biol Chem 279:7584–7590
Paulus WJ, Bronzwaer JG (2004) Nitric oxide’s role in the heart: control of beating or breathing? Am J Physiol Heart Circ Physiol 287:H8–H13
Seddon M, Shah AM, Casadei B (2007) Cardiomyocytes as effectors of nitric oxide signaling. Cardiovasc Res 75:315–326
Paulus WJ, Vantrimpont PJ, Shah AM (1995) Paracrine coronary endothelial control of left ventricular function in humans. Circulation 92:2119–2126
Shah AH, Spurgeon HA, Sollott SJ et al (1994) 8-Bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res 74:970–978
Layland J, Li J-M, Shah AM (2002) Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol (Lond) 540:457–467
Martin SR, Emanuel K, Sears CE et al (2006) Are myocardial eNOS and nNOS involved in the β-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc Res 70:97–106
Gyurko R, Kuhlencordt P, Fishman MC et al (2000) Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol 278:H971–H981
Khan SA, Skaf MW, Harrison RW et al (2003) Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 92:1322–1329
Shaul PW (2002) Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64:749–774
Barouch LA, Harrison RW, Skaf MW et al (2002) Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416:337–340
Brunner F, Andrew P, Wölkart G et al (2001) Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104:3097–3102
Martinez-Moreno M, Alvarez-Barrientos A, Roncal F et al (2005) Direct interaction between the reductase domain of the endothelial nitric oxide synthase and the ryanodine receptor. FEBS Lett 579:3159–3163
Vila-Petroff MG, Kim SH, Pepe S et al (2001) Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat Cell Biol 3:867–873
Linz W, Wohlfart P, Schölkens BA et al (1999) Review. Interactions among ACE, kinins and NO. Cardiovasc Res 43:549–561
Cornwell TL, Arnold E, Boerth NJ et al (1994) Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol Cell Physiol 267:C1405–C1413
Bath PMW, Hassall DG, Gladwin A-M et al (1991) Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb 11:254–260
Radomski MW, Palmer RMJ, Moncada S (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87:5193–5197
Garg UC, Hassid A (1990) Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/c 3T3 fibroblasts by a cyclic GMP-dependent mechanism. Biochem Biophys Res Commun 171:474–479
Arstall MA, Sawyer DB, Fukazawa R et al (1999) Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 85:829–840
Mungrue IN, Gros R, You X et al (2002) Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 109:735–743
Heger J, Gödecke A, Flögel U et al (2002) Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ Res 90:93–99
Flögel U, Merx MW, Gödecke A et al (2001) Myoglobin: a scavenger of bioactive NO. Proc Natl Acad Sci USA 98:735–740
Gödecke A, Molojavyi A, Heger J et al (2003) Myoglobin protects the heart from inducible nitric-oxide synthase (iNOS)-mediated nitrosative stress. J Biol Chem 278:21761–21766
Funakoshi H, Kubota T, Kawamura N et al (2002) Disruption of inducible nitric oxide synthase improves β-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ Res 90:959–965
Xu KY, Huso DL, Dawson TM et al (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 96:657–662
Sears CE, Bryant SM, Ashley EA et al (2003) Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 92:e52–e59
Meissner G (2004) Molecular regulation of cardiac ryanodine receptor ion channel. Cell Calcium 35:621–628
Danson EJ, Choate JK, Paterson DJ (2005) Cardiac nitric oxide: emerging role for nNOS in regulating physiological function. Pharmacol Ther 106:57–74
Dawson D, Lygate CA, Zhang MH et al (2005) nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112:3729–3737
Ashley EA, Sears CE, Bryant SM et al (2002) Cardiac nitric oxide synthase 1 regulates basal and β-adrenergic contractility in murine ventricular myocytes. Circulation 105:3011–3016
Khan SA, Lee K, Minhas KM et al (2004) Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci USA 101:15944–15948
Burkard N, Rokita AG, Kaufmann SG et al (2007) Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 100:e32–e44
Stoyanovsky D, Murphy T, Anno PR et al (1997) Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21:19–29
Jaffrey SR, Erdjument-Bromage H, Ferris CD et al (2001) Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3:193–197
Nakane M, Mitchell J, Förstermann U et al (1991) Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys Res Commun 180:1396–1402
Loyer X, Heymes C, Samuel JL (2008) Constitutive nitric oxide synthases in the heart from hypertrophy to failure. Clin Exp Pharmacol Physiol 35:483–488
Takimoto E, Champion HC, Li M et al (2005) Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodelling from chronic pressure load. J Clin Invest 115:1221–1231
Kuzkaya N, Weissmann N, Harrison DG et al (2003) Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric oxide synthase. J Biol Chem 278:22546–22554
Xia Y, Dawson VL, Dawson TM et al (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93:6770–6774
Rosen GM, Tsai P, Weaver J et al (2002) The role of tetrahydrobiopterin in the regulation of neuronal nitric-oxide synthase-generated superoxide. J Biol Chem 277:40275–40280
Hyndman ME, Verma S, Rosenfeld RJ et al (2002) Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 282:H2167–H2172
Stroes ES, van Faassen EE, Yo M et al (2000) Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 86:1129–1134
Bayraktutan U, Yang Z-K, Shah AM (1998) Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rats. Cardiovasc Res 38:719–726
Sanada S, Node K, Minamino T et al (2003) Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Hypertension 41:963–967
Wenzel S, Rohde C, Wingerning S et al (2007) Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes. Hypertension 49:193–200
Huang PL, Huang ZH, Mashimo H et al (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242
Ichinose F, Bloch KD, Wu JC et al (2004) Pressure overload-induced hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 286:H1070–H1075
Buys ES, Raher MJ, Blake SL et al (2007) Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodelling after chronic pressure overload. Am J Physiol Heart Circ Physiol 293:H620–H627
Bubikat A, de Windt LJ, Zetsche B et al (2005) Local ANP signalling prevents hypertensive cardiac hypertrophy in endothelial NO synthase (eNOS)-deficient mice. J Biol Chem 280:21594–21599
Moens AL, Takimoto E, Tocchetti CG et al (2008) Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin. Efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 117:2626–2636
Ozaki M, Kawashima S, Yamashita T et al (2002) Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J 66:851–856
Janssens S, Pokreisz P, Schoonjams L et al (2004) Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 94:1256–1262
Massion PB, Balligand JL (2007) Relevance of nitric oxide for myocardial remodeling. Curr Heart Fail Rep 4:18–25
Massion PB, Feron O, Dessy C et al (2003) Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93:388–398
Umar S, van der Valk EJ, Schalij MJ et al (2009) Integrin stimulation-induced hypertrophy in neonatal rat cardiomyocytes is NO-dependent. Mol Cell Biochem 320:75–84
Umar S, Hessel M, Steendijk P et al (2007) Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension. Pathol Res Pract 203:863–872
Zhang P, Xu X, Hu X et al (2007) Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 100:1089–1098
Pacher P, Schulz R, Liaudet L et al (2005) Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci 26:302–310
Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49:241–248
Mollnau H, Wendt M, Szöcs K et al (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:e58–e65
Turko IV, Murad F (2002) Protein nitration in cardiovascular diseases. Pharmacol Rev 54:619–634
Mihm MJ, Coyle CM, Schanbacher BL et al (2001) Peroxynitrite induced nitration and inactivation of myofibillar creatine kinase in experimental heart failure. Cardiovasc Res 49:798–807
Ferdinandy P, Danial H, Ambrus I et al (2000) Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87:241–247
Vaziri ND, Ni Z, Oveisi F et al (2002) Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39:135–141
Szabo C (2003) Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140–141:105–112
Wang W, Sawicki G, Schulz R (2002) Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res 53:165–174
Shiomi T, Tsutsui H, Matsusaka H et al (2004) Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109:544–549
Moens AL, Champion HC, Claeys MJ et al (2008) High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 117:1810–1819
Piech A, Massart PE, Dessy C et al (2002) Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 282:H219–H231
Drexler H, Kästner S, Strobel A et al (1998) Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol 32:955–963
Damy T, Ratajczak P, Shah AM et al (2004) Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363:1365–1367
Stein B, Eschenhagen T, Rüdiger J et al (1998) Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol 32:1179–1186
Fukuchi M, Hussain SNA, Giaid A (1998) Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure. Their relation to lesion site and β-adrenergic receptor therapy. Circulation 98:132–139
Gealekman O, Abassi Z, Rubinstein I et al (2002) Role of myocardial inducible nitric oxide synthase in contractile dysfunction and β-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation 105:236–243
Smith RS Jr, Agata J, Xia C-F et al (2005) Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 76:2457–24571
Jones SP, Greer JJM, van Haperen R et al (2003) Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci USA 100:4891–4896
Scherrer-Crosbie M, Ullrich R, Bloch KD et al (2001) Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104:1286–1291
Liu Y-H, Xu J, Yang X-P et al (2002) Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure. Hypertension 39:375–381
Feng Q, Fortin AJ, Lu X et al (1999) Effects of L-arginine on endothelial and cardiac function in rats with heart failure. Eur J Pharmacol 376:37–44
Haywood GA, Tsao PS, von der Leyen HE et al (1996) Expression of inducible nitric oxide synthase in human heart failure. Circulation 93:1087–1094
Vejlstrup NG, Bouloumie A, Boesgaard S et al (1998) Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J Mol Cell Cardiol 30:1215–1223
Chen Y, Traverse JH, Du R et al (2002) Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 106:273–279
Thoenes M, Förstermann U, Tracey WR et al (1996) Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 28:165–169
Heymes C, Vanderheyden M, Bronzwaer JGF et al (1999) Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 99:3009–3016
Feng Q, Lu X, Jones DL et al (2001) Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104:700–704
Sam F, Sawyer DB, Xie Z et al (2001) Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 89:351–356
Jones SP, Greer JJ, Ware PD et al (2005) Deficiency of iNOS does not attenuate severe congestive heart failure in mice. Am J Physiol Heart Circ Physiol 288:H365–H370
Liu Y-H, Carretero OA, Cingolani OH et al (2005) Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol 289:H2616–H2623
West MB, Rokosh G, Obal D et al (2008) Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation 118:1970–1978
Narula J, Haider N, Virmani R et al (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182–1189
Olivetti G, Abbi R, Quaini F et al (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131–1141
Damy T, Ratajczak P, Robidel E et al (2003) Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J 17:1934–1936
Bendall JK, Damy T, Ratajczak P et al (2004) Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in β-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 110:2368–2375
Kawakami M, Okabe E (1998) Superoxide anion radical-triggered Ca2+ release from cardiac sarcoplasmic reticulum through ryanodine receptor Ca2+ channel. Mol Pharmacol 53:497–503
Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93:903–907
Keith M, Geranmayegan A, Sole MJ et al (1998) Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31:1352–1356
Belch JJF, Bridges AB, Scott N et al (1991) Oxygen free radicals and congestive heart failure. Br Heart J 65:245–248
Saraiva RM, Minhas KM, Raju SVY et al (2005) Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction. Role of nitroso-redox equilibrium. Circulation 112:3415–3422
Casadei B (2006) The emerging role of neuronal nitric oxide synthase in the regulation of myocardial infarction. Exp Physiol 91:943–955
Kinugawa S, Huang H, Wang Z et al (2005) A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ Res 96:355–362
Gonzalez DR, Beigi F, Treuer AV et al (2007) Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci USA 104:20612–20617
Saraiva RM, Hare JM (2006) Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr Opin Cardiol 21:221–228
Barouch LA, Cappola TP, Harrison RW et al (2003) Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice. J Mol Cell Cardiol 35:637–644
Loyer X, Gómez AM, Milliez P et al (2008) Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 117:3187–3198
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Umar, S., van der Laarse, A. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem 333, 191–201 (2010). https://doi.org/10.1007/s11010-009-0219-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0219-x